Literature DB >> 16722659

Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors.

Anil Kumar1, Guofeng Ye, Yuehao Wang, Xiaofeng Lin, Gongqin Sun, Keykavous Parang.   

Abstract

A series of peptide analogues of Ac-CIYKYY (1) were synthesized by functional group modifications in peptide side chains or by introducing conformational constraints, to improve the inhibitory potency against active Src kinase. Ac-CIYKF(4-NO2)Y (2, IC50 = 0.53 microM) and conformationally constrained peptide 31 (IC50 = 0.28 microM) exhibited 750- and 1400-fold higher inhibitory activities, respectively, versus that of 1 (IC50 = 400 microM). Compound 2 exhibited a partial competitive inhibition pattern against ATP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722659      PMCID: PMC2527579          DOI: 10.1021/jm060334k

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Src inhibitors: genomics to therapeutics.

Authors:  T Sawyer; B Boyce; D Dalgarno; J Iuliucci
Journal:  Expert Opin Investig Drugs       Date:  2001-07       Impact factor: 6.206

Review 2.  A renaissance for SRC.

Authors:  Timothy J Yeatman
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

3.  The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts.

Authors:  D W Owens; G W McLean; A W Wyke; C Paraskeva; E K Parkinson; M C Frame; V G Brunton
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

4.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

Review 5.  Protein tyrosine kinase structure and function.

Authors:  S R Hubbard; J H Till
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

6.  Identification and characterization of a novel synthetic peptide substrate specific for Src-family protein tyrosine kinases.

Authors:  K S Lam; J Wu; Q Lou
Journal:  Int J Pept Protein Res       Date:  1995-06

7.  Development and characterization of potent and specific peptide inhibitors of p60c-src protein tyrosine kinase using pseudosubstrate-based inhibitor design approach.

Authors:  J R Kamath; R Liu; A M Enstrom; Q Lou; K S Lam
Journal:  J Pept Res       Date:  2003-12

8.  Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.

Authors:  Nguyen-Hai Nam; Rebecca L Pitts; Gongqin Sun; Soroush Sardari; Amie Tiemo; Mingxing Xie; Bingfang Yan; Keykavous Parang
Journal:  Bioorg Med Chem       Date:  2004-02-15       Impact factor: 3.641

9.  Use of synthetic peptides and copolymers to study the substrate specificity and inhibition of the protein tyrosine kinase pp60c-src.

Authors:  R J Budde; N U Obeyesekere; S Ke; J S McMurray
Journal:  Biochim Biophys Acta       Date:  1995-04-05

Review 10.  SRC family kinases: potential targets for the treatment of human cancer and leukemia.

Authors:  Markus Warmuth; Robert Damoiseaux; Yi Liu; Doriano Fabbro; Nathanael Gray
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

View more
  6 in total

Review 1.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Alex Brown; Dindyal Mandal; Gongqin Sun; Keykavous Parang
Journal:  Bioorg Med Chem Lett       Date:  2013-04-06       Impact factor: 2.823

3.  Peptide cyclization and cyclodimerization by Cu(I)-mediated azide-alkyne cycloaddition.

Authors:  Reshma Jagasia; Justin M Holub; Markus Bollinger; Kent Kirshenbaum; M G Finn
Journal:  J Org Chem       Date:  2009-04-17       Impact factor: 4.354

4.  Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling.

Authors:  Michel F Sanner; Khalid Zoghebi; Samara Hanna; Saghar Mozaffari; Simin Rahighi; Rakesh K Tiwari; Keykavous Parang
Journal:  J Chem Inf Model       Date:  2021-05-17       Impact factor: 6.162

5.  The Analysis of Cu(II)/Zn(II) Cyclopeptide System as Potential Cu,ZnSOD Mimic Center.

Authors:  Aleksandra Kotynia; Tomasz Janek; Żaneta Czyżnikowska; Sylwia Bielińska; Wojciech Kamysz; Justyna Brasuń
Journal:  Int J Pept Res Ther       Date:  2017-02-16       Impact factor: 1.931

6.  4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities.

Authors:  Ali Rafinejad; Asal Fallah-Tafti; Rakesh Tiwari; Amir Nasrolahi Shirazi; Deendayal Mandal; Abbas Shafiee; Keykavous Parang; Alireza Foroumadi; Tahmineh Akbarzadeh
Journal:  Daru       Date:  2012-12-26       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.